On Feb. 28, King Pharmaceuticals
- The top line grew by 21.2% due to higher sales of the Altace blood-pressure drug and the Skelaxin muscle relaxant.
- The company expanded its THROMBIN-JMI franchise by acquiring an exclusive license to Vascular Solutions' hemostatic products, used to check bleeding.
- King Pharmaceuticals says it will launch the new Altace tablets in the fourth quarter of 2007 or the first quarter of 2008.
- Among Motley Fool CAPS All-Stars, 96% have an outperform rating on the company.
(Figures in millions, except per-share data)
Income Statement Highlights
Q4 2006 |
Q4 2005 |
Change |
|
---|---|---|---|
Sales |
$512.9 |
$423.3 |
21.2% |
Net Profit* |
$37.1 |
($94.2) |
N/A |
EPS |
$0.15 |
($0.39) |
N/A |
Diluted Shares |
243.1 |
241.8 |
0.5% |
Get back to basics with a look at the income statement.
Margin Checkup
Q4 2006 |
Q4 2005 |
Change* |
|
---|---|---|---|
Gross Margin |
77.8% |
84.1% |
(6.3) |
Operating Margin |
8.2% |
(34.9%) |
43.1 |
Net Margin |
7.2% |
(22.3%) |
29.5 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$1,004.0 |
$524.7 |
91.3% |
Accounts Rec. |
$265.5 |
$223.6 |
18.7% |
Inventory |
$215.5 |
$228.1 |
(5.5%) |
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Accounts Payable |
$77.2 |
$84.5 |
(8.7%) |
Long-Term Debt |
$400.0 |
$345.0 |
15.9 |
Learn the ways of the balance sheet.
Cash Flow Highlights
No data was available.
Find out why Fools always follow the money.
Related Foolishness:
- King Not Loving Its Shareholders
- The Best Drug Stock for 2007: Endo Pharmaceuticals
- No Worries About Cephalon
Need new ideas for your money? Investors like you rate thousands of stocks on Motley Fool CAPS to help you with your own stock selections. It's fun --and it's free.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.